Conventional surgical closure through midline sternotomy is considered the gold standard in the treatment of children with secundum type atrial septal defect (ASD) due to very low mortality and morbidity rates among these children and the availability of long-term follow-up data available for this procedure. Recent advances in the use of minimally invasive surgical techniques (characterized by very small incisions with minimal exposure of the operative field) and of interventional percutaneous device applications are now challenging the role of the conventional approach, especially in the cases of small to medium sized defects. Supposed advantages of the new approaches include a more cosmetic skin incision, less postoperative pain, shorter hospital stay and earlier return to physical activity (1) (2) (3) (4) (5) . However, minimally invasive surgery appears more technically demanding than conventional surgery, while percutaneous closure entails the need for otherwise unnecessary intracardiac prostheses. Therefore, the issue of abandoning the well-established midline sternotomy approach in favor of the newer techniques remains highly controversial. The main argument is whether cosmetic and financial goals should divert the management philosophy toward more audacious solutions.
From March 1996 to November 1998, our institution offered three different techniques to pediatric patients with secundum ASD, that is, conventional sternotomic surgery, minimally invasive surgery and interventional deviceclosure. We retrospectively analyzed our experience regarding the efficacy and safety of minimally invasive surgery and percutaneous devices with respect to a control group of patients of similar age and weight treated by conventional midline sternotomy. Patient selection. All 171 consecutive patients with an isolated secundum ASD referred to our institution from March 1996 to December 1998 were included. Patients with partial anomalous pulmonary venous return or other associated defects were excluded. During this time frame, there was no established institutional policy for selecting any of the three available techniques for ASD closure. However, patients with an isolated and centrally located secundum ASD not exceeding a size of 20 mm and at a safe distance from the pulmonary veins, the mitral valve and the caval veins were generally referred for device closure. All candidates for percutaneous ASD closure had a 24-h day-hospital admission before the procedure for transesophageal echo-cardiography (TEE) screening to minimize the risk of aborted procedures in the catheterization laboratory. With respect to surgical indication for ASD closure, the choice of a minimally invasive surgical approach was initially based mostly on the personal confidence of the surgeon with this technique or, occasionally, on the parental preference.
METHODS
The following parameters were calculated: 1) mortality and morbidity (including all events causing a delayed discharge of the patient); 2) length of the procedure, that is, skin-toskin time for the surgical procedures and catheter incatheter out for the percutaneous approach (anesthesia induction time was not taken into account); 3) cardiopulmonary bypass and aortic cross-clamp times for the surgical groups; 4) duration of hospitalization (the amount of time from the procedure until the discharge from the hospital); and 5) costs. Operative techniques. PERCUTANEOUS CLOSURE. The technique was the same for each type of device and was always carried out by the same group of cardiologists.
After routine cardiac catheterization with oxymetric and pressure recordings, a Mullins sheath was advanced over an exchange guidewire into the left atrium. The device was inserted into the sheath and carefully deployed under TEE surveillance. Device release was followed by control rightatrial angiography. Fluoroscopic equipment was the same throughout all procedures, and, for echocardiographic assessment, a Sonos 2500 (Hewlett & Packard, Amsterdam, The Netherlands) echocardiograph was used. Antibiotic prophylaxis was given for 48 h, and aspirin was administered for six months. The follow-up schedule included a full clinical and transthoracic echocardiography (TTE) evaluation at one, three and six months after the procedure and yearly thereafter. Minimally invasive surgery. Minimally invasive surgery was carried out by all members of the surgical team (n ϭ 7). Information about the mean size of the defect is not available. The patient was placed with the right side elevated by 30 degrees. A 5-to 6-cm anterolateral right thoracotomy incision was performed at the level of the fifth intercostal space (Fig. 1) . The chest was entered through the third intercostal space. The pericardium was opened at least 2 cm anterior and parallel to the phrenic nerve, and a piece of it was harvested for later use as a patch. The ascending aorta was cannulated first, followed by cannulation of the inferior vena cava. A mildly-to-moderately hypothermic (30°C) cardiopulmonary bypass was instituted, and the superior vena cava was directly cannulated. Under mild general hypothermia, the ascending aorta was cross-clamped, and crystalloid cardioplegic solution was infused into the aortic root. The defect was closed through a right atriotomy. After discontinuation of the cardiopulmonary bypass, the thoracotomy was closed in a routine fashion.
The follow-up schedule after discharge was clinical and echocardiographic evaluations after one week, one month, six months and yearly thereafter. Midline sternotomy. The heart was reached through a classic midline sternotomy. Mildly hypothermic cardiopulmonary bypass was instituted through aortic and bicaval cannulations. During a short period of aortic crossclamping, transatrial defect closure was accomplished. The follow-up schedule was similar to that for minimally invasive surgery. Cost estimation. Costs were calculated on an individual basis to produce a "case cost" (6) , which is the sum of the variable individual direct costs (i.e., generic medical supplies like oxygen masks and intubation sets, delivery systems and devices in the case of percutaneous closure, oxygenator and bypass equipment in the case of surgery, time spent in the catheterization laboratory [operating room, intensive care unit, ward]). The costs of laboratory tests were not taken into account. Since the national health system in Italy is not comparable with a US Health Management Organization style system, we preferred avoiding calculation of the impact 
RESULTS
Patient demographics. Among 171 consecutive patients with isolated secundum ASD, 52 were evaluated as potential candidates for catheter closure of the defect but were secondarily referred to surgery because of unfavorable anatomy of the defect found at conventional TTE or TEE, while 67 were treated by primary surgical repair due to parental decision or lack of confidence of the referring cardiologist towards the percutaneous protocol. Percutaneous closure was considered feasible in 70 children, but 18 were crossed over to the surgical groups because the defect was too large at balloon stretching (n ϭ 17) or too close to the mitral valve (n ϭ 1) as detected during the invasive diagnostic procedure. Cardiac catheterization and subsequent device deployment attempt was finally carried out in 52 children (median 7.0 years, median weight 23 kg) using two types of devices, the Amplatzer (AGA Medical Corporation, Golden Valley, Minnesota) (41 patients) and the Microvena Angel Wings (Microvena Corporation, Vadnais, Minnesota) (11 patients). Average ASD diameter at TEE was 12.0 Ϯ 3.6 mm (14.6 Ϯ 4.1 mm mean stretch diameter), and mean Qp/Qs was 1.66 Ϯ 0.57. Mean follow-up was 41 Ϯ 2 months for the patients receiving the Angel Wings device and 18 Ϯ 13 months for the patients receiving the Amplatzer device.
Minimally invasive repair was accomplished from June 1996 to December 1998 in 71 patients (median age 5.1 years, median weight 20.5 kg) through a right submammary minithoracotomy by an autologous pericardial patch closure in 66 cases and direct closure in five cases. Femoral arterial cannulation was necessary in six cases (8.4%). Median follow-up time for this group was 19 months.
During the time frame considered for the study, conventional midline sternotomy repair was carried out in 50 cases (median age 5.1 years, median weight 18 kg). In 48 patients, a pericardial patch was used for repair, while in the other two, repair was accomplished by direct suture. Information about the mean size of the defects for the patients treated by surgery is not available. There were no significant differences among the three groups of patients in terms of age and weight.
Mortality and morbidity. There were no early or late deaths. Percutaneous closure. Two patients (3.8%) experienced complications. One patient had a pericardial tamponade 6 h after the implant of an Angel Wings device, requiring emergency surgery. A perforation was found on the anterior aortic wall, probably caused by the device.
In the other patient, a premature unscrewing from the delivery system of an Amplatzer device occurred, due to a series of maneuvers aimed at reversing an occurrence of the so-called "cobra" shaping of the device. Despite several attempts, the device failed to regain a flat shape and could not be adequately positioned across the atrial septum. Due to a large residual shunt, the patient had to be operated on the same day. There were no vascular complications. Minimally invasive thoracotomy. The overall rate of complications was 9.8% (7/71 patients), with four early (5.6%) and three late (4.2%) events. The short-term complications requiring a prolonged hospitalization were bleeding in one patient and transient sick sinus syndrome in three patients.
One late complication requiring readmission to the hospital consisted in patch dehiscence of the suture line with significant residual left-to-right shunt requiring reoperation (through the same minithoracotomy approach) after two weeks. Another two patients, one with postoperative pneumothorax and one with pericardial effusion, were treated conservatively and discharged after three and six days, respectively. Midline sternotomy. The overall rate of complications was 12% (6/50). Only one patient (2%) had an early event (atrial fibrillation lasting for 48 h with spontaneous reversion to sinus rhythm). The other five (10%), in the days after surgery, had transient atrial arrhythmias (one case), prolonged pericardial effusions (three cases) treated with steroids or aspirin and sternal wire granuloma (one case). Efficacy. No significant residual shunts were observed in this group of patients. In four cases treated with the Amplatzer device, there was a trivial to mild shunt immediately after the procedure, which disappeared after 24 h as shown by the follow-up TTE. There were no residual or recurrent shunts within the surgical groups. Hospital stay. The sternotomy group required the longest hospitalization time (6.5 Ϯ 2.1 days) followed by the minimally invasive (2.8 Ϯ 1.0 days) and percutaneous device (2.1 Ϯ 0.5 days) groups. The differences between the conventional and both the minimally invasive and percutaneous approaches were highly significant (p Ͻ 0.01). Procedure time. The minimally invasive approach was more time consuming (196 Ϯ 43 min) than either the device approach (118 Ϯ 58 min, p Ͻ 0.001) or the sternotomy approach (163 Ϯ 46 min, p Ͻ 0.01). The difference between the interventional and sternotomy groups was highly significant (p Ͻ 0.01).
Extracorporeal circulation and cross-clamping time.
Minithoracotomy required longer extracorporeal circulation times than cases treated with sternotomy (49. 13,000 Ϯ 300 ), while sternotomy was significantly more costly (15,000 Ϯ 1,050 , p Ͻ 0.01). Costs for the percutaneous group include the two cases submitted to surgery and represent a mean of the two types of devices used. The Amplatzer and Angel Wings had nearly the same individual cost (including selling price and delivery equipment).
DISCUSSION
Minimally invasive (possibly video-assisted) repairs of ASDs (7) and other types of congenital heart defects have recently been reported but are considered highly controversial (8) . The claimed advantages of minimally invasive surgical techniques are better cosmetic appearance and reduction of pain. These patients, compared with those undergoing transsternotomy ASD closure, supposedly have a smoother postoperative course and an earlier discharge time.
On the other hand, the increasing use of percutaneous ASD closure systems has proven that selected patients may be treated with as good results as those of conventional surgery, yet implying a shorter hospital stay and no scar at all. The related economic benefits further push the current trend towards fast-track strategies for the repair of uncomplicated secundum ASDs (9) . Moreover, recent studies report a subtle, but not minimal, superiority in the intellectual and psychological scores of patients treated by percutaneous device implantation compared with those treated by surgery (i.e., using extracorporeal circulation) (10) .
However, minimally invasive surgery may sometimes become quite challenging with complex arterial and venous cannulations and with a less-than-optimal view of the operating field, possibly implying unwarranted operating risks. Moreover, there is still some debate on whether a lateral minithoracotomy or a lower ministernotomy should be the incision sites of choice. A recent article strongly disputes the "minimal" aspect of reduced sternotomy techniques, showing similar results in terms of hospitalization, pain scores and stress indexes in a randomized trial versus conventional full-length sternotomy (11) .
On the other side, percutaneous ASD closure relies on the use of prosthetic material inside the heart, needs an adequate training for the operator and presents several structural pitfalls (e.g., potential device fracture, embolization or thromboembolic accidents).
Therefore, it is still unclear whether minimally invasive surgery or device implantation will definitively provide an adequate replacement of conventional surgery as primary choice(s), especially in children. Berger and coworkers (12) recently analyzed their experience comparing a subset of patients undergoing percutaneous defect closure with another group submitted to surgery. Their study comprised adults and older children (median 12 years), and no distinction was made between lateral minithoracotomy and conventional sternotomy within the surgical group, leading to an "unfair" comparison of hospital stay and resource utilization between the percutaneously and surgically treated groups. In addition, follow-up time was very limited for both groups. Since at our institution these three techniques were distinctively and simultaneously carried out for a limited time frame, we aimed at comparing the results using efficacy and safety parameters common to all three procedures (incidence of residual shunts and complication rates) as well as parameters concerning financial and management aspects. Morbidity. The number of complications was significantly higher in the surgical groups compared with the percutaneous group, leading to a generally longer hospital stay and a greater economical impact.
However, if one considers the severity of complications, the two serious events that occurred in the percutaneous group fairly outweigh the events that occurred in the surgical groups, making the statistical difference somewhat misleading. On the other hand, both events within the catheterization group should probably be considered as relatively rare and unlikely to recur.
It is noteworthy that the minimally invasive group had an incidence of complications similar to that of the sternotomy group (12% vs. 12.5%, p Ͼ 0.05). Again, this comparison is meaningful only with respect to economical issues (i.e., considering all the events producing a prolonged hospitalization). In fact, the patch dehiscence in one case of the minithoracotomy group should be regarded by far as the most important of all postsurgical problems, yet necessitating a re-do ASD closure. Although this case was operated on early in our experience, we acknowledge that limited surgical field, typical of lateral minithoracotomy, may have had an impact on the determination of a fractured suture line, ultimately resulting in patch dehiscence.
All things considered, stratifying complications by pure clinical impact score, conventional surgery still emerges as the safest technique (0% vs. 2.8% of minimally invasive surgery vs. 3.8% of the interventional technique). Efficacy. All patients eventually had successful closure of their defect. Based on our data showing a 100% closure rate in the percutaneous group, we endorse the equivalence in efficacy of the three different approaches. However, we are aware that the midterm follow-up results available from the literature concerning the Amplatzer system show a 92% to 95% complete closure rate. It should be emphasized, however, that there are no established criteria yet on whether to consider "successful closure" of an ASD only a "complete closure" or whether to include among successes those cases in which there is the presence of a trivial residual shunt. In
